forensics degree
March 10th, 2010 | | Make me happy!Stamps.com® (NASDAQ: STMP), the leading provider of postage online and shipping software solutions, today announced that the readers of Law Technology News (LTN) have selected Stamps.coms PC Postage® Version 8.0 as a “New Product of the Year.” The seventh annual LTN Awards, selected by LTNs 40,000 subscribers, recognize outstanding achievement in technology innovation serving the legal community. Law offices are currently one of the largest industry segments within Stamps.coms 400,000 customers.
Stamps.coms PC Postage provides features that are important to law offices of all sizes. It provides a complete record of every mailing done using the software, simplified preparation of Certified Mail and Return Receipt, easy integration with client billing codes to more easily track postage costs, and postage printing from popular software programs within the legal industry including Microsoft Word, QuickBooks and Corel WordPerfect.
“We are extremely honored to be recognized by the readers of Law Technology News for our innovative PC Postage product,” said Stamps.com president and CEO Ken McBride. “Winning the LTN Product of the Year award is a significant statement that Stamps.com offers a comprehensive solution for our legal customers mailing and shipping needs. We plan to continue innovating new solutions for our law office customers as well as for all of our customers this year and in the coming years.”
About Stamps.com
Stamps.com (NASDAQ: STMP) is a leading provider of Internet-based postage services. Stamps.coms service enables small businesses, enterprises, advanced shippers, and consumers to print U.S. Postal Service-approved postage with just a PC, printer and Internet connection, right from their home or office. The Company currently has PC Postage partnerships with Avery Dennison, Microsoft, HP, the U.S. Postal Service, Interapptive, TrueShip, Auctane, Atandra, Webgility and others.
The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Northern District of California on behalf of purchasers of the common stock of Medivation, Inc. (”Medivation” or the “Company”) (NASDAQ: MDVN) between July 17, 2008 and March 2, 2010, inclusive (the “Class Period”).
The Complaint charges that Medivation, a biopharmaceutical company, and certain of its officers and executives violated federal securities laws by issuing false and misleading statements regarding the Companys drug Dimebon. Specifically, throughout the Class Period, defendants disseminated false and misleading statements to the investing public about the effectiveness of Dimebon as a treatment for Alzheimers disease, making it impossible for shareholders to gain a meaningful or realistic understanding of the drugs progress toward FDA approval and market success. Then, on March 3, 2010, before the market opened, defendants were forced to publicly disclose that Dimebon did not meet primary and secondary goals in a Phase 3 trial for patients with mild to moderate Alzheimers disease. On this news, Medivations stock fell $27.15 per share to close at $13.10 per share on March 3, 2010 — a one-day decline of 67%.
If you are a member of the class, you may, no later than May 10, 2010, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a class member that acts on behalf of other class members in directing the litigation. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions which could affect the overall recovery for class members.
SAN DIEGO — Robbins
Umeda LLP has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of infoGROUP Inc. (”Infogroup”) (NASDAQ: IUSA) in
connection with their decision to pursue the sale of Infogroup to CCMP
Capital Advisors, LLC (”CCMP”). If the transaction is approved,
Infogroup shareholders will receive $8.00 in cash per share of Infogroup
common stock they hold. The deal is set to close early summer 2010.
Robbins Umeda LLPs investigation concerns whether Infogroups Board of
Directors acceptance and recommendation of CCMPs offer was the result
of a fair process designed to secure the best possible price for all
Infogroup shareholders.